Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Report: Estimated 6 Million Americans Suffer From Melasma—Skinspirations New RevLite SI Melasma Treatment Offers Relief for Stubborn Pigment
  • USA - English


News provided by

JoTo PR

Jan 12, 2015, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Skinspirations announces its new nonsurgical cosmetic procedure designed to minimize the effects of melasma that commonly affect women in their prime.
Skinspirations announces its new nonsurgical cosmetic procedure designed to minimize the effects of melasma that commonly affect women in their prime.
Youtube
Youtube

Melasma differs from other forms of hyperpigmentation, in that the discoloration often affects younger women with estrogen levels at their peak; the solution is treatment at the first sign of pigmentation, and prevention to hinder future flare-ups.

Post this

(PRWEB) January 12, 2015 -- According to the American Academy of Dermatology, an estimated six million people in the United States alone suffer from melasma—a patchy, symmetric tan or brown discoloration of the face that can be marked with persistent cycles of clearing and recurrence—making it a very frustrating skin condition to manage; 90% of those afflicted are women, due to the influence of estrogen. (1) In response, Tampa Bay cosmetic facility Skinspirations has introduced an evidence-based and staff-tested melasma treatment protocol which utilizes the new RevLite SI laser from Cynosure, a leading developer and manufacturer of light-based aesthetic and medical treatment systems. Skinspirations’ three-month, three-step program helps those with the unwanted skin condition banish unsightly skin discoloration.

Melasma, a subset of hyperpigmentation, typically appears on the forehead, cheeks, upper lip and chin. Melasma can also appear on the forearms and neck. People with darker skin—such as those of Hispanic, African-American, Asian, Indian, Middle Eastern and Mediterranean descent—are more prone to experiencing melasma; having a relative with the condition also puts one more at risk for the condition. (2)

In contrast to “typical age spots” that become visible around the late 30s to early 40s, melasma usually appears much earlier, (3) presenting a potential and worrisome complication for young women in their prime, according to Skinspirations owner Cynthia Elliott, M.D.: “Melasma differs from other forms of hyperpigmentation, in that the discoloration often affects younger women with estrogen levels at their peak; the solution is treatment at the first sign of pigmentation, and prevention to hinder future flare-ups.”

In order to effectively treat melasma and maintain long-term results, the treatment must both suppress the production of skin pigment (melanin) and remove excess pigment and pigment granules already present in the skin, both in the epidermis (top layer) and dermis (deep layer). Dr. Elliott cautions against trying at-home remedies to treat melasma, as they may aggravate the skin and make the condition worse.

Skinspirations’ three-step melasma treatment program combines professional office treatments with at-home skin care. This safe, simple and highly effective program has shown results after just one treatment. The process is broken down into the following steps:

1. Microdermabrasion—A professional mechanical exfoliation treatment gently removes surface pigment as well as dull, dry skin cells, to reveal smoother skin.

2. Cynosure RevLite SI laser Treatment—This step is performed immediately following microdermabrasion. The RevLite emits light in short, rapid pulses, targeting pigment molecules without causing any damage to the surrounding skin. As light shatters the pigment, the discolored patch may turn gray or white for a few minutes, as the skin absorbs the energy. The impact of the laser can feel like a snap of a thin rubber band. To maximize patient comfort, the area can be numbed with topical anesthetic approximately 30 minutes prior to treatment, although this step is not necessary. Post-treatment discomfort can feel similar to a mild sunburn, and any redness will dissipate within a day. The RevLite delivers more power to treat stubborn pigment, and has also been shown to be effective in the removal of multicolored tattoos.

3. Customized At-Home Skin Care Treatment—Customized products are provided, including high-quality, broad-spectrum sunscreen, topical Vitamin C (for its skin-lightening, collagen-stimulating and free radical neutralizing/antioxidant properties), Retinoid (to inhibit new pigment formation, enhance the penetration of skincare products, and speed skin cell turnover, reducing discoloration), and prescription strength 4% hydroquinone (skin lightener).

To prevent melasma, Dr. Elliott recommends minimizing sun exposure, as sunlight is a controllable trigger for melasma. Dr. Elliott stresses the importance of wearing sunscreen—even on cloudy days—and covering up the skin with protective clothing. A wide-brimmed hat and large sunglasses are simple and effective approaches to mitigating harmful damage from the sun.

About Dr. Cynthia Elliott and Skinspirations:

Cynthia Elliott, M.D., is the board-certified owner of Skinspirations, located in Clearwater, Florida. Dr. Elliott obtained her M.D. from the University of Illinois College of Medicine, and then completed her residency in Emergency Medicine at Denver General Hospital and the University of Colorado Health Sciences Center. She has been on staff at Bayfront Medical Center, St. Joseph’s Hospital, University Community Hospital and Mease Countryside Hospital, and has served on the faculty of the USF School of Medicine. Dr. Elliott currently serves as an expert witness in Cosmetic Medicine for the Florida Board of Medicine. Her company, ExpertEsthetics, provides hands on technique training for other practitioners. Dr. Elliott is also a national and international trainer for Cutera Lasers, training other physicians in the use of aesthetic lasers on skin of all colors. Skinspirations specializes exclusively in rejuvenation, enhancement and anti-aging treatments for the face and body. With her staff of aesthetic experts, you know you’ll get the best results obtainable. Dr. Elliott has been in practice for over 20 years, and has the experience and reputation to have been chosen by the makers of Botox® Cosmetic and Juvederm to train other physicians and practitioners in her techniques. For more information, visit http://www.skinspirations.com.
1. “Tips for Treating Melasma.” Skin Inc. Magazine, 25 Sept. 2013. Web. 7 Jan. 2015. skininc.com/treatments/facial/Tips-for-Treating-Melasma-225202192.html?utm_source=Related%2BItems&utm_medium=website&utm_campaign=Related%2BItems.

2. “Melasma: Who Gets and Causes.” American Academy of Dermatology, 2014. Web. 7 Jan. 2015. aad.org/dermatology-a-to-z/diseases-and-treatments/m---p/melasma/who-gets-causes.

3. Baumann, Leslie. “A Closer Look at Melasma.” N.p., 8 July 2014. Web. 7 Jan. 2015. miamiherald.com/living/health-fitness/skin-deep/article1974543.html.

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.